Shanshan Wang
Hubei University
10 Papers
4 Citations
Shanshan Wang is an academic researcher from Hubei University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.
Nan Wang,Yan Zhan,Linyu Zhu,Zhibing Hou,Feng Liu,Pinhong Song,Feng Qiu,Xiaolin Wang,Xiafei Zou,Deyun Wan,Xiaosong Qian,Shanshan Wang,Yabi Guo,Hao Yu,Miao Cui,Gangling Tong,Yunsheng Xu,Zhihua Zheng,Yingying Lu,Peng Hong,Peng Hong,Peng Hong +21 more
TL;DR: It is concluded that administration of IFN-α2b during the early stage of COVID-19 may induce favorable clinical responses and reduce mortality and accelerated recovery compared to lopinavir/ritonavir (LPV/r) alone.
295
Dach1 Deficiency Drives Alveolar Epithelium Apoptosis in Pulmonary Fibrosis via Modulating C-Jun/Bim Activity.
Yan Lu,K. Mary Tang,Shanshan Wang,Zhen Tian,Yan G Fan,Boyu Li,Meijia Wang,Jianping Zhao,Jungang Xie +8 more
TL;DR: In this article , the lungs collected from PF patients and mice of Bleomycin (BLM)-treated were characterized by low expression of Dachshund homolog 1 (Dach1), especially in AECII.
11
Club cell 10-kDa protein (CC10) as a surrogate for identifying type 2 asthma phenotypes
TL;DR: Lower plasma CC10 was associated with enhanced airway hyperresponsiveness, and Type 2 inflammation, and Plasma CC10 is potentially useful in predicting T2-high and T1-low asthma.
5
Sphingosine-1-Phosphate Receptor 4 Attenuates Neutrophilic Airway Inflammation in Experimental Asthma via Repressing Proinflammatory Macrophage Activation
Shanshan Wang,Zhe-Yu Tian,Yan Lu,Zhenli Huang,Yan G Fan,Boyu Li,Hongyan Zheng,Xiaojie Wu,Meijia Wang,Jianping Zhao,Jungang Xie +10 more
TL;DR: In this paper , the sphingosine-1-phosphate receptor 4 (S1PR4) deficiency aggravated the OVA/LPS-induced pulmonary inflammation in mice along with a significant up-regulation in M1 macrophage activation.
Interleukin-41 diminishes cigarette smoke-induced lung inflammation in mice.
Tiantian Cen,Yifeng Mai,Jie Jin,Minxuan Huang,Mingcai Li,Shanshan Wang,Hongying Ma +6 more
TL;DR: It is suggested that IL-41 could be used therapeutically to treat CS-induced lung inflammatory disorders as it inhibits CS- induced pulmonary inflammation when administered in vivo in mice.
3